Partell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
Partell Specialty Pharmacy is recalling Testosterone 100 mg pellets in Nevada because they were sterilized using a non-approved method.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. Per the rubric, FDA Class I or II recalls involving significant health risks (such as lack of sterility assurance) are categorized as Severe (4) or higher, and the rule states never to go below 4 for Class I/II classifications where significant injury risk is implied by the defect type.
Plain-English summary
Partell Specialty Pharmacy is recalling Testosterone 100 mg pellets packaged in amber vials. The recall is limited to products distributed in Nevada. The firm is conducting this recall because the drug products were sterilized using a non-approved method, which raises concerns about the assurance of sterility.
The recall includes multiple lots of the product with specific expiration dates ranging from March 2018 to August 2018. The source text does not specify the total number of units recalled or report any illnesses or injuries associated with the use of these products.
Consumers who have these specific lots of Testosterone 100 mg pellets should stop using them and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Testosterone 100 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
- Manufacturer
- Partell Specialty Pharmacy
- Category
- Drug — Injectable Sterile Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot#: 20171212@17
- BUD 06/10/2018
- 20180205@40
- BUD 08/04/2018
- 20180208@42
- BUD 08/07/2018
- 20170929@42
- BUD 03/28/2018
- 20171013@33
- BUD 04/11/2018
- 20171020@25
- BUD 04/18/2018
- 20171025@52
- BUD 04/23/2018
- 20171101@70
- BUD 04/30/2018
- 20171106@31
- BUD 05/05/2018
- 20171116@17
- BUD: 05/15/2018
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 49 recalled by Partell Specialty Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 49 products in this recall →Related recalls
Same manufacturer · Partell Specialty Pharmacy
See all →- SeverePartell Specialty Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Nandrolone Decanoate Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- HighPartell Specialty Pharmacy Recalls Estradiol Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
- SeverePartell Specialty Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-04-25
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- HighTestosterone Pellets Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereFDA Recalls Testosterone Pellets Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-04
- SevereFDA Recalls Testosterone Pellets Due to Lack of Sterility Assurance
FDA (Drugs) · 2015-11-04
- SevereTestosterone Sterile Pellets Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereTestosterone Pellets Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2015-09-23
- SevereMoses Lake Pharmacy Recalls Testosterone Pellets Due to Sterility Concerns
FDA (Drugs) · 2015-11-04